Skip to content

The complete low testosterone testing guide: What to order, when to test, and how to read results

Vladimir Kotlov, MD avatar
Vladimir Kotlov, MD: Founder & CEO at Veedma
Oct 19, 2026 · 17 min read

Listen to this article as a podcast episode

June 18, 2026 · 20:45

A proper low testosterone test starts with symptoms, then confirms deficiency with repeated fasting morning testosterone blood tests, free testosterone when it is needed, and LH and FSH. A low number alone is not a diagnosis, and symptoms alone are not enough either. This testosterone testing guide explains how to test for low testosterone accurately, which labs matter, and how the results change treatment.

Find the cause before treating it

Choose a lab panel and get a clinical review with clear next steps.

Order your lab panel

Key takeaways

  • A low testosterone test is diagnostic only when persistent symptoms and biochemical evidence are both present. A laboratory number by itself does not diagnose male hypogonadism.[1] [2] [3]
  • The testosterone blood test should be drawn fasting in the morning, between 07:00 and 11:00, and not during acute illness, because transient functional hypogonadism can falsely lower the result.[2] [3]
  • When free testosterone is needed, it should be measured by equilibrium dialysis or calculated with an accurate formula.[3] Direct free testosterone immunoassays are not accurate enough for clinical decisions and should be avoided.[3] [4]
  • According to the EAU guideline, testosterone therapy is generally ineffective when total testosterone is above about 350 ng/dL, and the clearest benefit is seen in more severe deficiency, especially below about 230 ng/dL.[2]
  • LH and FSH should always be measured with testosterone. High LH plus low testosterone indicates primary hypogonadism, and low or inappropriately normal LH plus low testosterone indicates secondary hypogonadism.[1] [2] [3] The pattern decides whether treatment should replace testosterone or stimulate the body’s own production.

How to test testosterone levels accurately

To test testosterone levels accurately, start with a morning fasting total testosterone blood test and repeat a low result on a separate morning. The Endocrine Society recommends checking free testosterone when total testosterone is near the lower limit or a condition changes sex hormone binding globulin (SHBG). Use equilibrium dialysis or an accurate calculation from total testosterone, SHBG and albumin.[3]

Review symptoms and recent illness with the clinician before interpreting the result. LH and FSH distinguish a testicular problem from reduced pituitary signaling. Total testosterone describes the circulating amount; free testosterone describes the unbound fraction. Neither result alone establishes hypogonadism without compatible symptoms and consistently low levels.[3]

Start with symptoms and context before ordering labs

A valid low testosterone test starts with symptoms and clinical context, not a laboratory number.[1] [2] [3] Low libido, fewer spontaneous erections, and fatigue are the kinds of changes that make testing meaningful.

Hypogonadism is a clinical syndrome in which persistent symptoms coexist with biochemical evidence of testosterone deficiency. According to the AUA guideline and the EAU guideline, the first step is to decide whether the man actually has symptoms and signs suggestive of androgen deficiency before any blood is drawn.[1] [2] The full syndrome definition is covered in the article on the clinical definition of low testosterone.

The same testosterone value can mean very different things in different men. A man with low libido, fewer spontaneous erections, fatigue, and a correctly drawn low testosterone blood test may have true hypogonadism. A man with no symptoms and a single borderline number may not. The Endocrine Society guideline recommends diagnosing hypogonadism only in men with symptoms and signs of testosterone deficiency and consistently low serum testosterone.[3]

Before ordering a low testosterone test, the provider should also review three practical issues. First, drugs and substances that interfere with testosterone production or interpretation should be identified. Second, concomitant metabolic disease should be documented, especially obesity, metabolic syndrome, and diabetes, because these commonly suppress the axis functionally. Third, possible contraindications to testosterone treatment, such as prostate cancer, elevated hematocrit, or untreated severe sleep apnea, should be recognized early so that testing is interpreted in a safe clinical context.[2] [3]

Testing only when there is a clinical question avoids turning a hormone panel into a screening exercise. It also avoids the opposite error, which is dismissing a clearly symptomatic man because his total testosterone looks “in range” on a single incomplete lab report.

When and how to do a testosterone blood test

The correct testosterone blood test is a fasting morning sample collected between 07:00 and 11:00 and measured with a reliable assay.[2] [3]

Assay means the laboratory method used to measure a hormone. According to the EAU guideline and the Endocrine Society guideline, testosterone is highest in the morning, so timing is part of the diagnosis.[2] [3] A blood draw done at 15:00 may understate a younger man’s true baseline, and a nonfasting draw may also shift the result downward.

The EAU guideline advises against testing during acute or critical illness, which can produce transient functional hypogonadism, a temporary, reversible suppression of the hypothalamic pituitary testicular axis rather than a stable baseline deficiency.[2] A low value measured during a febrile infection, after surgery, or during hospitalization can therefore misclassify a man as hypogonadal when the issue is short term physiological stress.

According to the AUA guideline, a diagnosis of low testosterone should be made only after two total testosterone measurements taken on separate occasions, both in the early morning.[1] Testosterone varies from day to day, so a single low or borderline result is not enough, especially when symptoms and laboratory data do not line up. Using the same laboratory method for both tests improves comparability.

Practical checklist for the day of testing

  • Schedule the draw between 07:00 and 11:00.
  • Arrive fasting.
  • Do not test during an acute illness or soon after hospitalization.
  • Use a reliable assay, ideally LC-MS/MS for sex steroids.[4]
  • Repeat the testosterone blood test on another morning if the result is low, borderline, or inconsistent with symptoms.[1] [3]

What to order in a complete low testosterone test

A complete low testosterone test includes total testosterone, free testosterone, LH, FSH, and a safety panel that explains cause, treatment relevance, and common confounders. The guidelines call for total testosterone and LH, free testosterone when total testosterone is borderline or SHBG is likely to be altered, and baseline hematocrit and prostate assessment before any testosterone treatment.[1] [2] [3]

Gonadotropins are the pituitary hormones LH and FSH that signal the testes. Hematocrit is the percentage of blood volume occupied by red blood cells. Both change treatment planning as well as diagnosis.

Core order set

TestWhy it belongs in a testosterone testing guide
Total testosterone, LC-MS/MSDefines the main serum testosterone concentration using mass spectrometry, which is less prone to bias than immunoassay at low concentrations.[4]
Free testosterone, equilibrium dialysis with LC-MS/MSDetects hidden testosterone deficiency when total testosterone looks acceptable but the unbound hormone is reduced.
LHClassifies primary versus secondary hypogonadism. Without LH, treatment selection is incomplete.
FSHCompletes pituitary testicular axis classification and adds fertility relevant context.
EstradiolProvides a baseline and helps identify out of range states that may affect symptoms and feedback signaling.
CBCChecks hematocrit before treatment and may also reveal anemia that can cause low energy.
Comprehensive Metabolic PanelAssesses liver and metabolic status, which can influence testosterone binding and the interpretation of free testosterone.
Vitamin DA common deficiency that is often checked when fatigue is part of the picture.
PSA, age 40 and olderEstablishes a baseline safety marker before hormonal treatment discussions.
Insulin, BMI above 25Adds metabolic context when excess weight raises the likelihood of functional hypogonadism and insulin resistance.

The aim of this list is not to order as many biomarkers as possible. It is to order the markers that change diagnosis, treatment choice, and safe follow-up.

Conditional add ons

Some tests are not needed in every man but become important in the right clinical setting. A lipid panel is useful, especially in overweight men, because dyslipidemia is common alongside insulin resistance and functional hypogonadism. A thyroid test, usually starting with TSH, is appropriate when symptoms could reflect thyroid disease rather than testosterone deficiency. Prolactin, a pituitary hormone, should be measured when low testosterone occurs with low or inappropriately normal LH, the pattern of secondary hypogonadism.[2] [3]

SHBG and free testosterone are linked in the order set. When free testosterone is measured directly by equilibrium dialysis, a separate SHBG result is not needed to estimate it. SHBG is needed when free testosterone is calculated from total testosterone, SHBG, and albumin. If labs came back “normal” despite symptoms, the article on why a normal testosterone result can still be misleading explains how incomplete testing can miss the problem.

Why the free testosterone test method matters

The method used for a free testosterone test determines whether the result is clinically usable.[3] [4]

A 2007 Endocrine Society position statement in JCEM on testosterone measurement concluded that laboratories should be judged on their ability to measure known testosterone concentrations accurately and precisely, not only on agreement with other laboratories using the same method.[4] Many routine laboratories still rely on immunoassays, which can be acceptable for total testosterone in some settings but are more prone to bias than LC-MS/MS, especially at the low concentrations seen in hypogonadal men.[4]

Why direct free testosterone immunoassays should be avoided

Direct free testosterone immunoassays, often called analog assays, are not accurate enough for diagnosis and should be avoided.[3] [4] A free testosterone result from one of these assays can mislead, so it is worth checking which method the laboratory used.

Why equilibrium dialysis is preferred

Equilibrium dialysis is the reference method for measuring free testosterone.[4] It physically separates free hormone from protein bound hormone, so it stays accurate when binding proteins distort the relationship between total testosterone and the fraction available to tissues.

This matters most in men whose total testosterone is not obviously low but whose free testosterone may still be deficient. Liver disease and aging can increase SHBG and reduce the biologically active fraction. A direct measurement exposes this deficiency without depending on a formula, and different published formulas do not always agree with each other.

How SHBG changes a testosterone level test

SHBG, sex hormone binding globulin, determines how much of a total testosterone result is available to tissues, so it matters whenever a total testosterone result is near the lower limit of normal or a condition that alters SHBG is present.[2] [3] A 1981 JCEM study of steroid hormone binding in human plasma estimated that in normal men about 44% of circulating testosterone is bound to SHBG (then called testosterone binding globulin), about 50% to albumin, about 4% to cortisol binding globulin, and about 2% circulates free.[5] The free and albumin bound fractions together make up bioavailable testosterone.

Because SHBG binds testosterone tightly, the same total level can mean very different things. High SHBG can hide a real deficiency behind a normal looking total, and low SHBG can make a total result look low when the usable fraction is adequate. The EAU guideline lists the most common reasons SHBG changes:[2]

  • SHBG goes up with: aging, liver disease, hyperthyroidism, HIV, smoking, and some drugs, including anticonvulsants, estrogens and thyroid hormone.
  • SHBG goes down with: obesity, insulin resistance, type 2 diabetes and metabolic syndrome, nonalcoholic fatty liver disease, hypothyroidism, acromegaly, Cushing’s disease, nephrotic syndrome, and some drugs, including glucocorticoids, growth hormone, testosterone and anabolic steroids.

For men with any of these conditions, the EAU guideline recommends assessing free testosterone rather than relying on total testosterone alone.[2] In practice, that means a morning sample, total testosterone by LC-MS/MS, and a free testosterone result that accounts for SHBG, either measured directly by equilibrium dialysis or calculated from SHBG and albumin.

How to read total and free testosterone results

Total and free testosterone results only carry meaning when symptoms are present and the sample was collected correctly. Each guideline sets its own total testosterone threshold. According to the EAU guideline, about 350 ng/dL, or 12 nmol/L, is a reliable threshold for total testosterone in symptomatic men.[2] The AUA guideline uses 300 ng/dL as a reasonable cut-off, based on two early morning measurements.[1] The Endocrine Society guideline uses the lower limit of the harmonized normal range for healthy nonobese young men, 264 ng/dL.[3] [6]

The EAU guideline also notes that testosterone therapy is generally ineffective when baseline total testosterone is above 350 ng/dL, while the highest benefit is seen in more severe hypogonadism, especially below 230 ng/dL, which is about 8 nmol/L.[2] In the Testosterone Trials, a 2016 NEJM randomized trial of 790 men aged 65 or older with total testosterone below 275 ng/dL and symptoms, one year of testosterone gel moderately improved sexual function and slightly improved mood, but did not improve vitality or walking distance.[7] Interpretation therefore cannot be reduced to “inside range” versus “outside range.”

Total testosterone resultHow to read it
Above 350 ng/dLBiochemical deficiency is less likely. Recheck timing, symptoms, free testosterone, and assay method before ruling hypogonadism out.
230 to 349 ng/dLGray zone. Symptoms, free testosterone, LH, and FSH decide whether the picture is clinically significant.
Below 230 ng/dLSevere biochemical deficiency. Treatment response is usually clearest in this range when symptoms are present.

Free testosterone requires a more nuanced reading. In the European Male Aging Study, a 2010 NEJM analysis of 3,369 men aged 40 to 79, late-onset hypogonadism was best identified by three sexual symptoms (poor morning erections, low sexual desire, and erectile dysfunction) together with total testosterone below 11 nmol/L, about 320 ng/dL, and free testosterone below 220 pmol/L, or 64 pg/mL.[8] Those are research criteria from one population, not a universal cut-off. Free testosterone also falls with age, and the single adult range printed on many reports does not show whether a result is typical for a man’s age.

A 2017 JCEM harmonization study of 9,054 men in four US and European cohorts found that a substantial part of the variation in testosterone between cohorts came from assay differences, and it set the harmonized range for healthy nonobese men aged 19 to 39 at 264 to 916 ng/dL.[6] Age-specific values in nonobese men were higher than in all men combined.[6] A “normal” flag therefore depends on which population and which assay the laboratory’s range comes from, and it can still be clinically unhelpful if the sample was mistimed or free testosterone was never measured.

How LH and FSH change the diagnosis and treatment path

LH and FSH should always be measured with testosterone, because low testosterone cannot be classified as primary or secondary without them.[1] [2] [3] They show whether the pituitary is sending an adequate signal to the testes, and therefore whether the problem begins in the brain or in the testes themselves.

Two men can have the same testosterone value and need different treatment because the problem starts in different places. The article on primary vs secondary hypogonadism covers the framework in more depth.

Primary pattern, high LH plus low testosterone

High LH plus low testosterone indicates primary hypogonadism.[2] [3] The pituitary is signaling strongly, but the testes are not responding. This is testicular failure. Enclomiphene will not correct it, because the testes cannot respond adequately to more stimulation. This is the pattern in which testosterone replacement is usually required.

Secondary pattern, low or normal LH plus low testosterone

Low or inappropriately normal LH plus low testosterone indicates secondary hypogonadism.[1] [2] Here, the testes may be intact, but the brain is not sending enough signal. Functional forms, linked to obesity, metabolic syndrome, type 2 diabetes, or medications, are the most common real world cause. This is the pattern in which enclomiphene can be considered. It blocks estrogen feedback at the hypothalamus, increases GnRH and LH, and stimulates the testes to produce testosterone. Unlike testosterone replacement, it preserves spermatogenesis and testicular function. Enclomiphene is not appropriate for primary hypogonadism.

Once symptoms, testosterone levels, and the LH and FSH pattern line up, treatment follows the cause: stimulation of the body’s own production for suitable secondary patterns, and replacement when the testes have failed. Testosterone replacement suppresses LH, FSH, and sperm production, which is why the Endocrine Society recommends against starting it in men planning fertility in the near term.[3] Starting testosterone without checking LH and FSH leaves the cause of the deficiency unclassified.

When prolactin and pituitary evaluation are needed

Elevated prolactin suppresses GnRH and can produce secondary hypogonadism. A high result should prompt a search for treatable causes, such as medications including antipsychotics and metoclopramide, or a pituitary adenoma, before testosterone therapy is considered.[2] [3]

Headache, visual disturbances, or signs of other pituitary hormone deficiencies raise the level of concern further and change the workup. The Endocrine Society recommends additional evaluation to find the cause in men confirmed to have androgen deficiency.[3] When these symptoms are present, the priority is finding that cause before treatment begins.

Myth vs fact

Myth: A low number alone diagnoses low testosterone

Fact: Male hypogonadism requires persistent symptoms plus biochemical evidence of deficiency. The AUA, EAU, and Endocrine Society all frame diagnosis as a syndrome, not as a lab value in isolation.[1] [2] [3]

Myth: Any time of day is fine for a testosterone blood test

Fact: Morning fasting testing is the standard, and acute illness should delay testing. A poorly timed or nonfasting draw can misstate baseline testosterone, especially in younger men.[2] [3]

Myth: A free testosterone immunoassay is good enough

Fact: Direct free testosterone immunoassays are not recommended for diagnostic use. The reference method is equilibrium dialysis, and an accurate calculation from total testosterone, SHBG, and albumin is the accepted alternative.[3] [4]

Myth: LH and FSH are optional add ons

Fact: LH and FSH determine whether hypogonadism is primary or secondary.[1] [2] [3] Without them, a clinician cannot tell whether a treatment that stimulates the testes, such as enclomiphene, could work.

Myth: A normal total testosterone rules out deficiency

Fact: Total testosterone can miss men with low free testosterone, particularly when SHBG is altered.[2] [3] That is why free testosterone, by equilibrium dialysis or an accurate calculation, belongs in the workup when total testosterone is borderline or SHBG is likely to be abnormal.

Bottom line

Testing for low testosterone starts with symptoms, then fasting morning labs drawn with accurate methods, including free testosterone, LH, and FSH, with a repeat measurement to confirm a low result. The most important part of reading results is not whether testosterone is low alone. It is whether LH and FSH show primary or secondary hypogonadism, because that determines whether stimulation therapy or replacement therapy makes sense. The Low Testosterone hub covers the full diagnostic and treatment roadmap.

Veedma offers testing that includes total and free testosterone measured by LC-MS/MS with LH and FSH, or a review of labs you already have. Its licensed providers follow a protocol that treats when free testosterone is below 100 pg/mL and symptoms persist, and prescribe enclomiphene or the enclomiphene plus tadalafil tablet when appropriate. Enclomiphene is not an FDA-approved drug; it is prescribed after a provider confirms the diagnosis and is compounded by a licensed U.S. pharmacy.

References

  1. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200:423-432. PMID: 29601923
  2. Salonia A, Capogrosso P, Boeri L, et al. European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Hypogonadism, Erectile Dysfunction, Premature Ejaculation, and Peyronie’s Disease. Eur Urol. 2025;88:76-102. PMID: 40340108
  3. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103:1715-1744. PMID: 29562364
  4. Rosner W, Auchus RJ, Azziz R, et al. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2007;92:405-13. PMID: 17090633
  5. Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab. 1981;53:58-68. PMID: 7195404
  6. Travison TG, Vesper HW, Orwoll E, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. J Clin Endocrinol Metab. 2017;102:1161-1173. PMID: 28324103
  7. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016;374:611-24. PMID: 26886521
  8. Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363:123-35. PMID: 20554979

Start with a lab panel

Get a clinical review of your results and health history, with an explanation of the decision and next steps in your patient chat. If you are eligible and want treatment, choose a plan and save a card to book a video visit at no extra visit fee. Treatment billing starts only if prescribed.

Order your lab panel

Prefer short video breakdowns? Follow @veedma.men on TikTok for quick, study-backed men's hormone explainers.

Vladimir Kotlov, MD

Vladimir Kotlov, MD: Founder & CEO at Veedma

Vladimir Kotlov, MD is the founder of Veedma. A urologist by training, he led a urology department at a fertility and reproductive clinic where he managed a team of 30+ clinicians and improved IVF outcomes by 24%. He then moved to Silicon Valley and spent five years advising healthtech companies before founding Veedma to help men access evidence-based hormone optimization and fertility care.